NASDAQ: ADILAdial Pharmaceuticals Inc Stock Ownership - Who owns Adial Pharmaceuticals?
Insider buying vs selling
Have Adial Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when ADIL insiders and whales buy or sell their stock.
ADIL Shareholders
What type of owners hold Adial Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Cary J. Claiborne | 23.12% | 1,520,000 | $1.04M | Insider |
| William B. Stilley Iii | 21.20% | 1,393,920 | $956.23k | Insider |
| Bankole A. Johnson | 13.27% | 872,720 | $598.69k | Insider |
| James W. Newman Jr. | 6.67% | 438,742 | $300.98k | Insider |
| Joseph Truluck | 4.03% | 265,139 | $181.89k | Insider |
| Robertson H. Gilliland | 1.66% | 109,424 | $75.06k | Insider |
| Geode Capital Management LLC | 0.94% | 61,847 | $42.43k | Institution |
| Citadel Advisors LLC | 0.83% | 54,508 | $37.39k | Institution |
| Manchester Capital Management LLC | 0.73% | 48,097 | $32.99k | Institution |
| Renaissance Technologies LLC | 0.72% | 47,613 | $32.66k | Institution |
ADIL vs Biotech Stocks
Adial Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.